Minami A, Kasai M, Mizushima Y, Takeichi N, Hosokawa M, Kobayashi H
Cancer Res. 1980 Jul;40(7):2129-34.
Antiimmune responses in rats previously immunized with soluble tumor antigens prepared by sodium deoxycholate (DOC-STA) from chemically induced fibrosarcoma KMT-17 were measured by the Winn assay. Enhancement of tumor growth was demonstrated at a tumor:effector ratio of 1:500 with DOC-STA-immune spleen cells, although inhibition of tumor growth was demonstrated at a tumor:effector ratio of 1:100. The tumor-neutralizing ability of KMT-17-immune spleen cells was abrogated when DOC-STA-immune spleen cells were added to a mixture of KMT-17 cells and KMT-17-immune spleen cells. This suppressor activity of the spleen cells was diminished by the treatment with rabbit anti-rat T-cell serum and immune complement. The suppressor activity of DOC-STA-immune spleen cells was also shown in 51Cr release assay and was specific for the tumor line used. After fractionation of spleen cells from DOC-STA-immune rats by the Ficoll density gradient, the cells in the light layer showed an enhancing effect on tumor growth detected by the Winn assay, whereas the cells in the heavier region of the gradient had an inhibiting effect.
采用温氏试验测定了用脱氧胆酸钠(DOC - STA)从化学诱导的纤维肉瘤KMT - 17制备的可溶性肿瘤抗原预先免疫的大鼠的抗免疫反应。当肿瘤与效应细胞比例为1:500时,DOC - STA免疫的脾细胞可促进肿瘤生长,而当肿瘤与效应细胞比例为1:100时,则显示肿瘤生长受到抑制。当将DOC - STA免疫的脾细胞加入KMT - 17细胞和KMT - 17免疫的脾细胞的混合物中时,KMT - 17免疫的脾细胞的肿瘤中和能力被消除。用兔抗大鼠T细胞血清和免疫补体处理后,脾细胞的这种抑制活性减弱。DOC - STA免疫的脾细胞的抑制活性在51Cr释放试验中也有体现,且对所用的肿瘤细胞系具有特异性。通过Ficoll密度梯度对DOC - STA免疫大鼠的脾细胞进行分离后,轻层中的细胞通过温氏试验检测显示对肿瘤生长有促进作用,而梯度较重区域的细胞则有抑制作用。